✦ LIBER ✦

PCN71 Cost-Effectiveness Analysis of Cetuximab and Panitumumab as First-Line Therapies for Metastatic Colorectal Cancer in Spain

✍ Scribed by V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ibáñez de Cáceres; Á. Ayuso; J.M. Peña; R. Perona; E. Grande; C. Belda-Iniesta

Book ID: 119312357
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 72 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.2111

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN118 COST EFFECTIVENESS OF CETUXIMAB I

PCN118 COST EFFECTIVENESS OF CETUXIMAB IN FIRST LINE TREATMENT OF METASTATIC COLORECTAL CANCER: DESCRIPTION OF A NICE SUBMISSION

✍ SG Eggington; D Garrell; I Griebsch; Y Samyshkin 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

NICE guidance on cetuximab, bevacizumab,

NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy

✍ Fiona Rinaldi; Elisabeth George; Amanda I Adler 📂 Article 📅 2012 🏛 The Lancet 🌐 English ⚖ 43 KB

PCN40 Year to Year Budget Impact Analysi

PCN40 Year to Year Budget Impact Analysis of Biological Therapies for First-Line Treatment of Metastatic Colorectal Cancer in Spain

✍ B. Martínez-Amores; L. Mezquita; I. Ibáñez de Cáceres; Á Ayuso; J.M. Peña; R. Pe 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN88 Cost-Effectiveness Analysis Per Li

PCN88 Cost-Effectiveness Analysis Per Life-Year Gained Based on Predictors of Response for First Line Metastasic Colorectal Cancer Therapy in Spain

✍ C. Belda-Iniesta; V. Moreno; B. Martínez-Amores; J. Barriuso; L. Mezquita; I. Ib 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

CH1: COST-EFFECTIVENESS ANALYSIS OF IRIN

CH1: COST-EFFECTIVENESS ANALYSIS OF IRINOTECAN AS FIRST-LINE THERAPY IN ADVANCED COLORECTAL CANCER

✍ C Schmitt; C Levy-Piedbois; M Frappe; I Durand-Zaleski 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Cost-effectiveness evaluation of sunitin

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain

✍ Emiliano Calvo Aller; Pablo Maroto; Noémi Kreif; José Luis González Larriba; Mar 📂 Article 📅 2011 🏛 Springer Milan 🌐 Spanish ⚖ 451 KB